Interleukin-38 ameliorates poly(I:C) induced lung inflammation
$ 16.00 · 4.5 (71) · In stock
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression
Protective effect of β-glucan on Poly(I:C)-induced acute lung injury/inflammation: Therapeutic implications of viral infections in the respiratory system - ScienceDirect
Inhibition of Polyinosinic-Polycytidylic Acid-Induced Acute Pulmonary Inflammation and NF-κB Activation in Mice by a Banana Plant Extract
Molecules, Free Full-Text
Interleukin-38 in Health and Disease - ScienceDirect
Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections
Department of Chemical Pathology, The Chinese University of Hong Kong
Role of interleukins in the pathogenesis of pulmonary fibrosis
Frontiers Circulating interleukin-38 concentrations in healthy adults
Early IFN-β administration protects cigarette smoke exposed mice against lethal influenza virus infection without increasing lung inflammation
Enhancing autophagy in CD11c+ antigen-presenting cells as a therapeutic strategy for acute respiratory distress syndrome - ScienceDirect
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression
Frontiers Research progress on the effect of traditional Chinese medicine on the activation of PRRs-mediated NF-κB signaling pathway to inhibit influenza pneumonia